Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Zynerba Pharmaceuticals (ZYNE) Plans Public Offering of Common Stock
-
Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Jun 30
-
PlacementTracker Publishes First Half 2018 PIPE Market League Tables
-
Heron Therapeutics (HRTX) PT Raised to $50 at Cantor Fitzgerald
-
Evolus (EOLS) Prices Prices 4M Share Common Offering at $20/Sh
-
Evolus, Inc. Announces Pricing of Public Offering of Common Stock
-
Orchid Island Capital Announces July 2018 Monthly Dividend and June 30, 2018 RMBS Portfolio Characteristics
-
Ra Medical Systems Files Registration Statement for Proposed Initial Public Offering
-
Fed's Powell: Years of strong jobs, low inflation still ahead
-
Dollar firms after Fed chair's upbeat remarks, global stocks gain
-
Trilogy Metals Reports Second Quarter Fiscal 2018 Financial Results
-
Evolus (EOLS) Announces Proposed 5M Share Common Offering
-
Evolus, Inc. Announces Proposed Public Offering of Common Stock
-
SELLAS Life Sciences Announces Closing of $24.2 Million Public Offering
-
Exotix Capital hires executives to expand fixed income presence
-
Mod-pac Corp (MPAC) Announces Merger with U.S. Well Services LLC
-
Matlin & Partners Acquisition Corporation and U.S. Well Services, LLC Enter Business Combination
-
Thunder Bridge Acquisition, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing July 17, 2018
-
Teva Pharma (TEVA) PT Raised to $25 at Cantor Fitzgerald
-
Spero Therapeutics (SPRO) Prices 3.78M Share Offering at $12.50/Sh
-
Spero Therapeutics Announces Pricing of Securities Offering
-
AcelRx Pharma (ACRX) Prices 7.27M Share Offering at $2.75/Sh
-
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Pre-Open Movers 07/12: (ZGNX) (GLMD) (CA) Higher; (ZN) (ACRX) (AVGO) Lower (more...)
-
SELLAS Life Sciences (SLS) Prices Upsized $24.2 Million Public Offering of Common Stock, Warrants
-
SELLAS Life Sciences Announces Pricing of Upsized $24.2 Million Public Offering
-
Cantor Raises Biohaven (BHVN) PT To $50 After CEO and CFO Meetings
-
After-Hours Stock Movers 7/11: (GLMD) (CA) (WFT) Higher; (ZN) (MYOV) (AVGO) Lower (more...)
-
AcelRx Pharma (ACRX) to Offer Common Stock
-
AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Galmed Pharmaceuticals (GLMD) at Overweight
-
The Ensign Group Inc. (ENSG) PT Raised to $42 at Cantor Fitzgerald
-
Spero Therapeutics (SPRO) Commences 4.5M Common Stock Offering
-
Spero Therapeutics Announces Proposed Offering of Common Stock
-
Cerner (CERN) Partnership With Lumeris is Positive - Cantor
-
Cantor Fitzgerald Reiterates Outperform on Aclaris Therapeutics (ACRS) Following FDA Fast Track Designation
-
Stark Office Suites Expands New York City Footprint
-
Allegro Merger Corp. Announces Closing of $149,500,000 Initial Public Offering
-
Allegro Merger Corp. Announces Closing of $149,500,000 Initial Public Offering
-
Cerner (CERN) PT Raised to $80 at Cantor Fitzgerald
-
WellCare Health Plans (WCG) PT Raised to $275 at Cantor Fitzgerald
-
U.S. yields fall as Wall Street turns lower
-
Efficient Market Advisors Named to Financial Times' 2018 List of Top 300 RIAs
-
Allegro Merger Corp. (ALGRU) Prices 13M Unit IPO at $10/Unit
-
Allegro Merger Corp. Announces Pricing of $130,000,000 Initial Public Offering
-
Allegro Merger Corp. Announces Pricing of $130,000,000 Initial Public Offering
-
Pre-Open Movers 07/02: (ADMP) (VMW) (TSLA) Higher; (MDXG) (MLCO) (LVS) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Melinta Therapeutics Inc. (MLNT) at Overweight

